LiteStepper Single Lower-Limb Exoskeleton Robot

LiteStepper® represents a breakthrough in rehabilitation robotics as the world’s first single lower-limb exoskeleton system designed specifically for hemiplegia patients. Developed by Angelexo and approved by NMPA in September 2022, the device fills a critical gap in neurological rehabilitation by enabling targeted training of the affected limb while the patient’s healthy leg moves naturally.

Product Overview

Traditional dual-leg exoskeletons control both lower limbs through preset programs, requiring patients to follow predetermined movement patterns regardless of their individual capabilities. LiteStepper® takes a fundamentally different approach—it monitors the healthy limb’s natural gait and synchronizes the affected limb’s movement accordingly, enabling a more physiologically natural rehabilitation process.

This human-machine fusion approach transforms rehabilitation from passive mechanical training into active neural recovery, using brain plasticity principles to rebuild motor control pathways. The patient drives their own recovery by walking with their healthy leg, while the system provides precisely calibrated assistance to the affected side.

Key Features

LiteStepper’s intelligent gait learning system enables single-limb rehabilitation by capturing the healthy leg’s movement and synchronizing hip and knee assistance on the affected side in real time — NMPA-approved in September 2022 as the world’s first single lower-limb exoskeleton.

• Intelligent Gait Learning: Real-time capture and analysis of healthy limb movement patterns
• Adaptive Motor Control: Patient-specific assistance levels adjusted based on individual recovery progress
• Healthy-Affected Limb Synchronization: Coordinated movement between natural and assisted limbs
• Neural Pathway Reconstruction: Designed to promote brain plasticity through active participation
• Rapid Donning System: Quick-wear exoskeleton design for efficient clinical workflows
• Multi-sensor Integration: Redundant sensor arrays for precise movement tracking

Technical Specifications

LiteStepper’s multi-sensor adaptive control synchronizes hip and knee assistance to the patient’s healthy-leg gait in real time, with adjustable thigh and shank settings, LCD touchscreen interface, and battery power for NMPA Class II-approved single-limb operation.

Clinical Applications

LiteStepper® addresses rehabilitation needs across multiple neurological and orthopedic conditions:

Stroke Rehabilitation: Unilateral motor dysfunction following cerebrovascular events represents the primary application. The device helps patients rebuild gait patterns while minimizing compensatory movements that can impede long-term recovery.

Traumatic Brain Injury: Patients with single-side motor impairment from head trauma benefit from the targeted approach that doesn’t restrict healthy limb movement.

Post-Orthopedic Surgery: Single-limb recovery following joint replacement or fracture repair, where the patient can walk naturally on the unaffected side while receiving assisted training on the surgical limb.

Neurological Conditions: Muscle atrophy, weakness, and gait abnormalities resulting from peripheral nerve injury or other neurological disorders affecting one lower limb.

Regulatory Status

The September 2022 NMPA approval marked a milestone not only for Angelexo but for the global rehabilitation robotics field, establishing the first regulatory pathway for single lower-limb exoskeleton devices.

Recognition and Awards

LiteStepper® has received industry recognition including:

• Selected as one of the “Top 100 Most Innovative Medical Technology Products of 2022”
• Won Industrial Design Award in 2023

Clinical Adoption

The device has been integrated into clinical research and treatment programs at institutions including the National Rehabilitation Aids Research Center, Tongji University Affiliated Yangzhi Rehabilitation Hospital, Zhejiang University affiliated hospitals, and Zhengzhou University Fifth Affiliated Hospital.

Mobile robot-assisted lower limb gait training has been included in the medical insurance catalogs of multiple Chinese provinces and cities, reducing patient access barriers for exoskeleton rehabilitation services.

Frequently Asked Questions

What conditions can LiteStepper® treat?

LiteStepper® is indicated for patients with unilateral lower-limb motor dysfunction, including stroke survivors, traumatic brain injury patients, post-orthopedic surgery rehabilitation, and individuals with muscle atrophy or gait abnormalities from neurological conditions affecting one leg.

How is LiteStepper® different from dual-leg exoskeletons?

Unlike dual-leg systems that control both limbs through preset programs, LiteStepper® only assists the affected limb while allowing the healthy leg to move naturally. This enables intelligent gait learning—the system captures how the patient’s healthy leg moves and guides the affected leg to follow similar patterns, promoting active neural recovery rather than passive mechanical training.

Is LiteStepper® covered by insurance in China?

Mobile robot-assisted lower limb gait training has been included in medical insurance catalogs in multiple Chinese provinces and cities. Coverage varies by region, with Beijing being among the early adopters with a reimbursement rate of 222 RMB per session.